CT2 Trademark

Trademark Overview

On Wednesday, December 15, 2004, a trademark application was filed for CT2 with the United States Patent and Trademark Office. The USPTO has given the CT2 trademark a serial number of 78533114. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, January 11, 2017. This trademark is owned by Critical Therapeutics, Inc.. The CT2 trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatory pharmaceutical products for the treatment of asthma
ct2

General Information

Serial Number78533114
Word MarkCT2
Filing DateWednesday, December 15, 2004
Status800 - REGISTERED AND RENEWED
Status DateWednesday, January 11, 2017
Registration Number3325888
Registration DateTuesday, October 30, 2007
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2005

Trademark Statements

Amendment to a Registration/Renewal CertificateISSUE NEW CERTIFICATE TO: CHIESI USA, INC., Delaware Corporation, 1255 CRESCENT GREEN DRIVE, SUITE 250, CARY, North Carolina 27518
Goods and ServicesAnti-inflammatory pharmaceutical products for the treatment of asthma
Pseudo MarkCRITICAL THERAPEUTICS TWO

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 28, 2004
Primary Code005
First Use Anywhere DateWednesday, December 7, 2005
First Use In Commerce DateWednesday, December 7, 2005

Trademark Owner History

Party NameCHIESI USA, INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCary, NC 27518
Party NameCORNERSTONE THERAPEUTICS INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressCARY, NC 27518
Party NameCritical Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameCritical Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameCritical Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Tuesday, August 18, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 18, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 18, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 18, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 18, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, January 11, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, January 11, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, January 11, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, January 10, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 7, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 7, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 1, 2016TEAS SECTION 8 & 9 RECEIVED
Tuesday, November 1, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, October 30, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, April 7, 2015NEW CERTIFICATE UNDER SECTION 7 ¿ PROCESSED
Tuesday, March 17, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 17, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 17, 2015TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, January 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 21, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 13, 2015POST REGISTRATION ACTION MAILED - SEC. 7
Tuesday, January 13, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, January 9, 2015TEAS SECTION 7 REQUEST RECEIVED
Wednesday, May 14, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, April 23, 2014REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Wednesday, April 23, 2014TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, January 21, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, January 20, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, January 20, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 31, 2012TEAS SECTION 8 & 15 RECEIVED
Wednesday, April 1, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, January 7, 2009ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 7, 2009TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 30, 2007REGISTERED-PRINCIPAL REGISTER
Monday, September 24, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, September 24, 2007ASSIGNED TO LIE
Monday, August 20, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 3, 2007STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 29, 2007USE AMENDMENT FILED
Tuesday, May 29, 2007PAPER RECEIVED
Wednesday, May 30, 2007EXTENSION 3 GRANTED
Monday, February 26, 2007EXTENSION 3 FILED
Monday, February 26, 2007PAPER RECEIVED
Wednesday, October 18, 2006EXTENSION 2 GRANTED
Wednesday, September 6, 2006EXTENSION 2 FILED
Friday, September 8, 2006PAPER RECEIVED
Saturday, February 18, 2006EXTENSION 1 GRANTED
Thursday, January 26, 2006EXTENSION 1 FILED
Thursday, January 26, 2006PAPER RECEIVED
Tuesday, September 6, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2005PUBLISHED FOR OPPOSITION
Wednesday, May 25, 2005NOTICE OF PUBLICATION
Saturday, February 19, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, February 18, 2005ASSIGNED TO LIE
Tuesday, February 15, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 15, 2005ASSIGNED TO EXAMINER
Tuesday, December 28, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

treatment asthma products pharmaceutical inflammatory anti